CPHARM - CRC Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-75
SponsorMonash University Malaysia

About this trial

Colorectal cancer is one of the most common cancers in Malaysia and worldwide. Although it can often be prevented or treated successfully when detected early, many people in Malaysia are diagnosed at an advanced stage. Screening tests, such as the immunochemical faecal occult blood test (iFOBT), can help detect early signs of colorectal cancer; however, participation in screening remains low.

Community pharmacies are easily accessible healthcare settings where people frequently seek health advice. Pharmacists may play an important role in improving awareness and encouraging colorectal cancer screening by providing education and support. However, more information is needed to understand how people perceive and respond to pharmacy-based colorectal cancer screening.

Eligibility criteria

Qualifiers

Adults aged 50 to 75 years

Visiting participating community pharmacies during the study period

Able to provide informed consent

Willing to complete the study questionnaire

Disqualifiers

Previous diagnosis of colorectal cancer

History of colonoscopy within the recommended screening interval (within past 1 year)

Currently experiencing symptoms suggestive of colorectal cancer

Having a first-degree relative diagnosed with colorectal cancer

Trial design

Treatments tested in this trial

  • Health awareness campaign

Treatment groups

316 Participants
are divided into 2 treatment groups

Sponsors and collaborators